VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Leap Therapeutics, Inc. (LPTX) Total Return Calculator with Dividends Reinvested

Leap Therapeutics, Inc.

Popular:

The total return for Leap Therapeutics, Inc. (LPTX) stock is +129.66% over the past 12 months. So far it's down 31.89% this year. The 5-year total return is -95.19%, meaning $10,000 invested in LPTX stock 5 years ago would be worth $481 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in LPTX 1 year ago, it would be worth $22,529 today — you'd have gained $12,529.

With Dividends Reinvested$22,529+125.29%

Price Only (No DRIP)$22,529+125.29%

Period2025-05-07 → 2026-04-01

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in LPTX

1Y$22,966+$12,966 (+129.7%)129.7% CAGR

3Y$1,973-$8,027 (-80.3%)-41.8% CAGR

5Y$481-$9,519 (-95.2%)-45.5% CAGR

10Y$98-$9,902 (-99.0%)-37.0% CAGR

15Y$98-$9,902 (-99.0%)-26.5% CAGR

20Y$98-$9,902 (-99.0%)-20.7% CAGR

30Y$98-$9,902 (-99.0%)-14.3% CAGR

Leap Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading LPTX total return...

As of 2026-05-06

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-31.89%	—	-31.89%	—	$6,811
1Y	+129.66%	129.66%	+129.66%	—	$22,966
3Y	-80.27%	-41.78%	-80.27%	—	$1,973
5Y	-95.19%	-45.50%	-95.19%	—	$481
10Y	-99.02%	-37.04%	-99.02%	—	$98
15Y	-99.02%	-26.54%	-99.02%	—	$98
20Y	-99.02%	-20.65%	-99.02%	—	$98
30Y	-99.02%	-14.29%	-99.02%	—	$98

Risk & Highlights

Best Year+112.26%2020

Worst Year-86.57%2022

Max Drawdown-82.21%2025-11-18 → 2026-03-06

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-44.78%	-44.78%	—	+0.41%	-45.2pp
2025	-63.98%	-63.98%	—	+16.64%	-80.6pp
2024	-38.33%	-38.33%	—	+24.00%	-62.3pp
2023	-3.72%	-3.72%	—	+24.81%	-28.5pp
2022	-86.57%	-86.57%	—	-19.95%	-66.6pp

LPTX outperformed the S&P 500 by 98.34pp over the past year (+129.66% vs +31.32%).

Loading summary...

LPTX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
LPTXLeap Therapeutics, Inc.	$65M	—	-31.9%	+129.7%	—	-80.3%	-95.2%	-99.0%
IMVTImmunovant, Inc.	$5.8B	+15.2%	+10.7%	+107.2%	—	+48.4%	+73.9%	+188.1%
AGENAgenus Inc.	$137M	+3.2%	+20.4%	+31.0%	—	-87.8%	-93.1%	-93.5%
TGTXTG Therapeutics, Inc.	$6.7B	+24.6%	+43.3%	+20.4%	—	+26.8%	+5.3%	+425.9%
RCUSArcus Biosciences, Inc.	$2.6B	+16.9%	+11.6%	+220.2%	—	+31.0%	-13.7%	+52.9%
NKTRNektar Therapeutics	$1.7B	+13.9%	+96.0%	+783.6%	—	+636.7%	-69.4%	-57.6%
MGNXMacroGenics, Inc.	$191M	-5.3%	+87.0%	+104.8%	—	-58.4%	-90.6%	-83.4%
ZYMEZymeworks Inc.	$2.1B	+6.8%	+3.7%	+135.2%	—	+215.2%	-6.4%	+112.4%
ALLOAllogene Therapeutics, Inc.	$530M	-11.2%	+71.1%	+80.5%	—	-63.4%	-92.1%	-90.8%
FATEFate Therapeutics, Inc.	$264M	+92.4%	+131.3%	+139.1%	—	-58.0%	-97.0%	+33.9%
MRKMerck & Co., Inc.	$280.5B	-6.1%	+7.5%	+47.9%	+4.2pp	+3.9%	+73.3%	+171.4%

Compare:LPTX vs IMVT LPTX vs AGEN LPTX vs TGTX LPTX vs IMVT vs AGEN

About LPTX Dividend Returns

Leap Therapeutics, Inc. (LPTX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of LPTX over the past year?

Leap Therapeutics, Inc. (LPTX) delivered a return of 129.66% over the past year. Since LPTX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in LPTX be worth today?

A $10,000 investment in Leap Therapeutics, Inc. one year ago would be worth $22,966 today, representing a gain of $12,966.

Q3Does LPTX pay dividends?

Leap Therapeutics, Inc. (LPTX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For LPTX, the total return equals the price-only return.

Q4Did LPTX beat the S&P 500?

Yes, Leap Therapeutics, Inc. (LPTX) outperformed the S&P 500 by 98.34 percentage points over the past year. LPTX delivered a total return of 129.66%, compared to the S&P 500's 31.32%. This 98.34pp alpha means investors in LPTX earned more than a passive S&P 500 index fund.

Q5What is LPTX's worst drawdown?

Leap Therapeutics, Inc. (LPTX) experienced a maximum drawdown of -82.21% over the past year, declining from its peak on 2025-11-18 to its trough on 2026-03-06. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is LPTX's long-term total return over 10, 20, or 30 years?

Here are Leap Therapeutics, Inc. (LPTX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.0% (-37.0% CAGR) — $10,000 would have grown to $98. Over 20 years: -99.0% total return (-20.7% CAGR) — $10,000 → $98. Over 30 years: -99.0% total return (-14.3% CAGR) — $10,000 → $98. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was LPTX's best and worst year?

Leap Therapeutics, Inc.'s best calendar year was 2020 with a total return of 112.3%. Its worst year was 2022 with a total return of -86.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 198.8 percentage points.